187 related articles for article (PubMed ID: 2114360)
1. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
Finke M; Duchêne M; Eckhardt A; Domdey H; von Specht BU
Infect Immun; 1990 Jul; 58(7):2241-4. PubMed ID: 2114360
[TBL] [Abstract][Full Text] [Related]
2. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
[TBL] [Abstract][Full Text] [Related]
4. Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.
Finke M; Muth G; Reichhelm T; Thoma M; Duchêne M; Hungerer KD; Domdey H; von Specht BU
Infect Immun; 1991 Apr; 59(4):1251-4. PubMed ID: 1706316
[TBL] [Abstract][Full Text] [Related]
5. [Study on Construction of Recombinant Bb-pGEX-
Liu X; Li WG; Luo GX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082
[TBL] [Abstract][Full Text] [Related]
6. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
[TBL] [Abstract][Full Text] [Related]
7. [Production of hybrid protein OprF-OprL of Pseudomonas aeruginosa].
Kaloshin AA; Mikhaĭlova NA; Leonova EI
Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):35-43. PubMed ID: 22830272
[TBL] [Abstract][Full Text] [Related]
8. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
[TBL] [Abstract][Full Text] [Related]
9. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
Baumann U; Mansouri E; von Specht BU
Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
[TBL] [Abstract][Full Text] [Related]
10. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
Mansouri E; Blome-Eberwein S; Gabelsberger J; Germann G; von Specht BU
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):161-6. PubMed ID: 12832120
[TBL] [Abstract][Full Text] [Related]
11. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
von Specht BU; Knapp B; Muth G; Bröker M; Hungerer KD; Diehl KD; Massarrat K; Seemann A; Domdey H
Infect Immun; 1995 May; 63(5):1855-62. PubMed ID: 7729895
[TBL] [Abstract][Full Text] [Related]
12. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
[TBL] [Abstract][Full Text] [Related]
13. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB
Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
Arnold H; Bumann D; Felies M; Gewecke B; Sörensen M; Gessner JE; Freihorst J; von Specht BU; Baumann U
Infect Immun; 2004 Nov; 72(11):6546-53. PubMed ID: 15501786
[TBL] [Abstract][Full Text] [Related]
15. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
[TBL] [Abstract][Full Text] [Related]
16. [Immunization with Bifidobacterium bifidum-vectored OprI vaccine of Pseudomonas aeruginosa enhances inhibitory effect on P. aeruginosa in mice].
Liu X; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1040-1044. PubMed ID: 28871943
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.
von Specht BU; Lücking HC; Blum B; Schmitt A; Hungerer KD; Domdey H
Vaccine; 1996 Aug; 14(12):1111-7. PubMed ID: 8911006
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Mansouri E; Gabelsberger J; Knapp B; Hundt E; Lenz U; Hungerer KD; Gilleland HE; Staczek J; Domdey H; von Specht BU
Infect Immun; 1999 Mar; 67(3):1461-70. PubMed ID: 10024596
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
[TBL] [Abstract][Full Text] [Related]
20. A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa.
Knapp B; Hundt E; Lenz U; Hungerer KD; Gabelsberger J; Domdey H; Mansouri E; Li Y; von Specht BU
Vaccine; 1999 Mar; 17(13-14):1663-6. PubMed ID: 10194820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
